Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities

被引:6
|
作者
Teoh, Jeremy Yuen-Chun [1 ]
Ng, Chi-Fai [1 ]
Eto, Masatoshi [2 ]
Chiruvella, Mallikarjuna [3 ]
Capitanio, Umberto [4 ]
Esen, Tarik [5 ]
Zeng, Guohua [6 ,7 ]
Lechevallier, Eric [8 ]
Andonian, Sero [9 ]
de la Rosette, Jean [10 ]
机构
[1] Chinese Univ Hong Kong, SH Ho Urol Ctr, Dept Surg, Hong Kong, Peoples R China
[2] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka, Japan
[3] Asian Inst Nephrol & Urol, Dept Urol, Hyderabad, Telangana, India
[4] Univ Vita Salute, San Raffaele Sci Inst, Unit Urol, Milan, Italy
[5] Koc Univ Hosp, Dept Urol, Istanbul, Turkey
[6] Guangzhou Med Univ, Dept Urol, Affiliated Hosp 1, Guangzhou, Peoples R China
[7] Guangzhou Med Univ, Guangdong Key Lab Urol, Affiliated Hosp 1, Guangzhou, Peoples R China
[8] Aix Marseille Univ, Concept Acad Hosp, AP HM, Dept Urol & Kidney Transplantat, Marseille, France
[9] McGill Univ, Div Urol, Montreal, PQ, Canada
[10] Istanbul Medipol Univ, Medipol Mega Univ Hosp, Dept Urol, Istanbul, Turkey
关键词
Age; ASA; Charlson Comorbidity Index; Nephroureterectomy; Urothelial carcinoma; UTUC; UROTHELIAL CARCINOMA; CANCER; LYMPHADENECTOMY; OUTCOMES;
D O I
10.1007/s00345-022-04152-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose We investigated the effects of age, American Society of Anesthesiologists Physical Status Classification (ASA) grading and Charlson Comorbidity Index (CCI) on the survival outcomes of upper tract urothelial carcinoma (UTUC). Methods The CROES-UTUC registry was an international, multicenter study on patients with UTUC. Primary outcomes were overall survival (OS) and disease-free survival (DFS). Kaplan-Meier and multivariate Cox regression analyses were performed by stratifying patients according to their age (<= 70 and > 70 years old) and ASA grade (I-II and III-V)/CCI (0-1 and >= 2). Results A total of 2352 patients were included in this study. Patients aged <= 70 years with ASA grading of I-II (p = 0.002), and patients aged <= 70 years with a CCI of 0-1 (p = 0.002) had the best OS. Upon multivariate analysis, both in patients aged <= 70 and > 70 years, ASA grading and CCI were not significantly associated with OS. Patients aged <= 70 years with ASA grading of III-IV (p = 0.024) had the best DFS. When stratified according to age and CCI, no significant difference in DFS was noted. Upon multivariate analysis, radical nephroureterectomy (RNU) was significantly associated with better DFS in patients aged <= 70 and > 70 years; CCI of >= 3 was significantly associated with worse DFS in patients <= 70 years; ASA grading was not associated with DFS in patients aged <= 70 and > 70 years. Conclusions A high ASA grading and CCI should not be considered contraindications for RNU. RNU should be considered even in elderly patients when it is deemed feasible and achievable after a geriatric assessment.
引用
收藏
页码:2657 / 2665
页数:9
相关论文
共 50 条
  • [21] Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage
    Buchner, Alexander
    Grimm, Tobias
    Schneevoigt, Birte-Swantje
    Wittmann, Georg
    Kretschmer, Alexander
    Jokisch, Friedrich
    Grabbert, Markus
    Apfelbeck, Maria
    Schulz, Gerald
    Gratzke, Christian
    Stief, Christian G.
    Karl, Alexander
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (02) : 130 - 136
  • [22] Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study
    Ishihara, Hiroki
    Kondo, Tsunenori
    Omae, Kenji
    Takagi, Toshio
    Iizuka, Junpei
    Kobayashi, Hirohito
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 136 - 144
  • [23] Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines
    Upfill-Brown, Alexander
    Lenis, Andrew T.
    Faiena, Izak
    Salmasi, Amirali H.
    Johnson, David C.
    Pooli, Aydin
    Drakaki, Alexandra
    Gollapudi, Kiran
    Blumberg, Jeremy
    Pantuck, Allan J.
    Chamie, Karim
    WORLD JOURNAL OF UROLOGY, 2019, 37 (06) : 1157 - 1164
  • [24] Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration
    Soria, Francesco
    Giordano, Andrea
    D'Andrea, David
    Moschini, Marco
    Roupret, Morgan
    Margulis, Vitaly
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Bensalah, Karim
    Mathieu, Romain
    Chlosta, Piotr
    Babjuk, Marek
    Glybochko, Petr V.
    Enikeev, Dmitry V.
    Remzi, Mesut
    Gust, Kilian
    Gontero, Paolo
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (06) : 602.e11 - 602.e19
  • [25] Survival Benefits Based on the Number of Lymph Nodes Removed during Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis
    Choo, Min Soo
    Yoo, Sangjun
    Yuk, Hyeong Dong
    Jeong, Chang Wook
    Cho, Min Chul
    Kwak, Cheol
    Jeong, Hyeon
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 11
  • [26] Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival
    Martini, Alberto
    Lonati, Chiara
    Necchi, Andrea
    Galsky, Matthew D.
    Ploussard, Guillaume
    Fallara, Giuseppe
    Pellegrino, Antony
    Simeone, Claudio
    Suardi, Nazareno
    Zamboni, Stefania
    Krajewski, Wojciech
    Simone, Giuseppe
    Briganti, Alberto
    Montorsi, Francesco
    Mattei, Agostino
    Shariat, Shahrokh F.
    Moschini, Marco
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 389.e1 - 389.e7
  • [27] Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy
    Mouracade, Pascal
    Velten, Michel
    Gigante, Marc
    Alenda, Olivier
    Ploussard, Guillaume
    Obadia, Frederic
    Timsit, Marc Olivier
    Mejean, Arnaud
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 (01) : 6105 - 6110
  • [28] No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study
    Burger, Maximilian
    Shariat, Shahrokh F.
    Fritsche, Hans-Martin
    Ignacio Martinez-Salamanca, Juan
    Matsumoto, Kazumasa
    Chromecki, Thomas F.
    Ficarra, Vincenzo
    Kassouf, Wassim
    Seitz, Christian
    Pycha, Armin
    Tritschler, Stefan
    Walton, Thomas J.
    Novara, Giacomo
    WORLD JOURNAL OF UROLOGY, 2011, 29 (04) : 465 - 472
  • [29] Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis
    Seisen, Thomas
    Colin, Pierre
    Hupertan, Vincent
    Yates, David R.
    Xylinas, Evanguelos
    Nison, Laurent
    Cussenot, Olivier
    Neuzillet, Yann
    Bensalah, Karim
    Novara, Giacomo
    Montorsi, Francesco
    Zigeuner, Richard
    Remzi, Mesut
    Shariat, Shahrokh F.
    Roupret, Morgan
    BJU INTERNATIONAL, 2014, 114 (05) : 733 - 740
  • [30] Adjuvant Systemic Therapy Improved Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
    Di Bello, Francesco
    Jannello, Letizia Maria Ippolita
    Siech, Carolin
    de Angelis, Mario
    Penaranda, Natali Rodriguez
    Tian, Zhe
    Goyal, Jordan A.
    Ruvolo, Claudia Colla
    Califano, Gianluigi
    Creta, Massimiliano
    Morra, Simone
    Saad, Fred
    Shariat, Shahrokh F.
    de Cobelli, Ottavio
    Briganti, Alberto
    Chun, Felix K. H.
    Puliatti, Stefano
    Longo, Nicola
    Karakiewicz, Pierre I.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 7229 - 7236